PPARA and metabolic dysfunction-associated steatohepatitis: Its expression was decreased in livers of NASH animals as compared with values observed in the Control group (34% of control, P < .05), Silibinin treatment failed to return the expression of PPAR-α to control levels (Figure 6(b)).